With the influx of “new drug applications” taking up a larger percentage of labor hours, the FDA had to turn to some other alternatives for help. The agency already has a program in place from the 1990s, called the Prescription Drug User Fee Act (PDUFA), which outlines the guidelines and metrics for the FDA to review a drug. Drug companies pay significant fees to the agency when submitting their applications, which now totals more than $2.8 trillion for trials involving clinical data.
В Израиле одним словом оценили ход операции против Ирана14:58
。Line官方版本下载是该领域的重要参考
至于未来最高领袖的继任安排，根据伊朗宪法，在最高领袖去世后，其继任者由专家会议选举产生，该机构由88名什叶派高级神职人员组成，他们需尽快选出继任者。，更多细节参见电影
通过 CLAUDE_ALLOWED_TOOLS 等做 allowlist/disallowlist，详见 docs/tools.md
魔法原子回应创始人离职：确有此事，目前技术团队稳定